Overview

Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTS

Status:
Unknown status
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness and safety of Naftopidil and Tamsulosin in the treatment of lower urinary tract symptoms through a comparative study of patients with benign prostatic hyperplasia.
Phase:
Phase 3
Details
Lead Sponsor:
Apsen Farmaceutica S.A.
Treatments:
Naftopidil
Tamsulosin